INVESTORS

Ascorbico has assembled a strong leadership team made of experienced and dedicated industry  veterans committed to pursue this highly lucrative project.
The company present novel formulation has been U.S.P.T.O patent registration with the company intention to use this novel discovery to suit the different therapeutic paths:

the diabetes Type 2 sector and the Obesity sector.

To carry out the company ambitious tasks, improve the project financial structure, conclude full scale human trials and initiate collaboration with one of the world Food / Superfood / Functional Food, Ascorbico is seeking $ 3 M.